1. Home
  2. CWST vs BLTE Comparison

CWST vs BLTE Comparison

Compare CWST & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Casella Waste Systems Inc.

CWST

Casella Waste Systems Inc.

HOLD

Current Price

$96.75

Market Cap

5.3B

Sector

Utilities

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$151.34

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWST
BLTE
Founded
1975
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
6.0B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
CWST
BLTE
Price
$96.75
$151.34
Analyst Decision
Buy
Strong Buy
Analyst Count
11
9
Target Price
$108.40
★ $228.89
AVG Volume (30 Days)
★ 614.9K
134.3K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,836,841,000.00
N/A
Revenue This Year
$14.54
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 17.95
N/A
52 Week Low
$74.05
$90.84
52 Week High
$107.96
$200.00

Technical Indicators

Market Signals
Indicator
CWST
BLTE
Relative Strength Index (RSI) 66.13 42.37
Support Level $87.22 $146.86
Resistance Level $97.47 $151.41
Average True Range (ATR) 3.19 5.83
MACD 1.57 -0.30
Stochastic Oscillator 96.55 47.11

Price Performance

Historical Comparison
CWST
BLTE

About CWST Casella Waste Systems Inc.

Casella Waste Systems Inc is a solid waste removal company, providing resource management services to residential, commercial, municipal, and industrial customers. The company's reportable segments on Geographical basis include Eastern, Western and Mid-Atlantic regions through the Resource solution segment. It generates maximum revenue from the Western region segment. The company's services include Recycling, Collection, Organics, Energy, Landfills, Special Waste as well as Professional Services.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: